Concepedia

Michael Reuman

MR

20

Publications

1K

Citations

14

H-Index

1980

Active since

Affiliations

Johnson & Johnson (United States)(Current)

South College

Winthrop University

UCB Pharma (United Kingdom)

Sterling Research Group (United States)

Michael Reuman is an author at Johnson & Johnson (United States) specializing in pharmacology, organic chemistry, and drug discovery.

Top concepts

Publications per year

1980–2014

20

Publications

20

The synthetic utility of oxazolines in aromatic substitution

Michael Reuman, A. I. MEYERS · Tetrahedron · 1985 · 321 citations

, , +2

Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect against Hepatic Metabolism

Guy D. Diana, Patrick J. Rudewicz, Daniel C. Pevear et al. · Journal of Medicinal Chemistry · 1995 · 104 citations

, , +20

Identification and Structure−Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms

Nareshkumar Jain, Jiayi Xu, Ramesh M. Kanojia et al. · Journal of Medicinal Chemistry · 2009 · 99 citations · Full text

Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives

Mark P. Wentland, George Y. Lesher, Michael Reuman et al. · Journal of Medicinal Chemistry · 1993 · 73 citations · Full text

Nucleophilic annulations of aromatics. Novel route to benzo-fused ring systems via oxazoline activation

A. I. MEYERS, Michael Reuman, Richard A. Gabel · The Journal of Organic Chemistry · 1981 · 47 citations

, , +11

Rows per page

1–5 of 20